Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Intravenous Furosemide for Acute Decompensated Congestive Heart Failure: What Is the Evidence?

Owen DR, MacAllister R, Sofat R.

Clin Pharmacol Ther. 2015 Aug;98(2):119-21. doi: 10.1002/cpt.120. Epub 2015 Jun 30. Review.

2.
3.

Furosemide in acute decompensated heart failure.

[No authors listed]

Prescrire Int. 2012 Dec;21(133):303.

PMID:
23373103
4.

Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.

Cotter G, Weissgarten J, Metzkor E, Moshkovitz Y, Litinski I, Tavori U, Perry C, Zaidenstein R, Golik A.

Clin Pharmacol Ther. 1997 Aug;62(2):187-93.

PMID:
9284855
6.

Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis.

Matsue Y, Shiraishi A, Kagiyama N, Yoshida K, Kume T, Okura H, Suzuki M, Matsumura A, Yoshida K, Hashimoto Y.

Heart Vessels. 2016 Dec;31(12):1980-1987. Epub 2016 Feb 18.

PMID:
26892531
7.

Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.

Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S.

Am Heart J. 2003 Mar;145(3):459-66.

PMID:
12660669
8.

Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.

Vargo DL, Kramer WG, Black PK, Smith WB, Serpas T, Brater DC.

Clin Pharmacol Ther. 1995 Jun;57(6):601-9.

PMID:
7781259
9.

Troponin I release after intravenous treatment with high furosemide doses plus hypertonic saline solution in decompensated heart failure trial (Tra-HSS-Fur).

Parrinello G, Di Pasquale P, Torres D, Cardillo M, Schimmenti C, Lupo U, Iatrino R, Petrantoni R, Montaina C, Giambanco S, Paterna S.

Am Heart J. 2012 Sep;164(3):351-7. doi: 10.1016/j.ahj.2012.05.025. Epub 2012 Aug 17.

PMID:
22980301
10.

Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure.

Gottlieb SS, Skettino SL, Wolff A, Beckman E, Fisher ML, Freudenberger R, Gladwell T, Marshall J, Cines M, Bennett D, Liittschwager EB.

J Am Coll Cardiol. 2000 Jan;35(1):56-9.

11.

Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.

Thomson MR, Nappi JM, Dunn SP, Hollis IB, Rodgers JE, Van Bakel AB.

J Card Fail. 2010 Mar;16(3):188-93. doi: 10.1016/j.cardfail.2009.11.005. Epub 2010 Jan 6.

PMID:
20206891
12.

The Effect of Furosemide Dose Administered in the Out-of-hospital Setting on Renal Function Among Patients with Suspected Acute Decompensated Heart Failure.

Nieves LC, Mehrtens GM, Pores N, Pickrell C, Tanis J, Satty T, Chuang M, Young TC, Merlin MA.

Prehosp Disaster Med. 2015 Feb;30(1):38-45. doi: 10.1017/S1049023X14001411. Epub 2015 Jan 16.

PMID:
25592809
13.

A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.

de Denus S, Rouleau JL, Mann DL, Huggins GS, Cappola TP, Shah SH, Keleti J, Zada YF, Provost S, Bardhadi A, Phillips MS, Normand V, Mongrain I, Dubé MP.

Pharmacogenomics J. 2017 Mar;17(2):192-200. doi: 10.1038/tpj.2016.4. Epub 2016 Mar 1.

14.
15.

Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy.

Zenuk C, Healey J, Donnelly J, Vaillancourt R, Almalki Y, Smith S.

Can J Clin Pharmacol. 2003 Winter;10(4):184-8.

PMID:
14712323
16.

[Hear failure. Indications for diuretic therapy in general practice].

[No authors listed]

MMW Fortschr Med. 2003 May 1;145(18):55. German. No abstract available.

PMID:
12808825
17.
18.

Which dosing of furosemide is better in acute decompensated heart failure?

Jalaba S, Palermo J, Budavari AI.

JAAPA. 2017 Mar;30(3):11-12. doi: 10.1097/01.JAA.0000512242.43624.7a. Review.

PMID:
28221314
19.

Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial.

Llorens P, Miró Ò, Herrero P, Martín-Sánchez FJ, Jacob J, Valero A, Alonso H, Pérez-Durá MJ, Noval A, Gil-Román JJ, Zapater P, Llanos L, Gil V, Perelló R.

Emerg Med J. 2014 Sep;31(9):706-13. doi: 10.1136/emermed-2013-202526. Epub 2013 Jun 22.

PMID:
23793945
20.

Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.

Triposkiadis FK, Butler J, Karayannis G, Starling RC, Filippatos G, Wolski K, Parissis J, Parisis C, Rovithis D, Koutrakis K, Skoularigis J, Antoniou CK, Chrysohoou C, Pitsavos C, Stefanadis C, Nastas J, Tsaknakis T, Mantziari L, Giannakoulas G, Karvounis H, Kalogeropoulos AP, Giamouzis G.

Int J Cardiol. 2014 Mar 1;172(1):115-21. doi: 10.1016/j.ijcard.2013.12.276. Epub 2014 Jan 10.

PMID:
24485633

Supplemental Content

Support Center